Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Osteoblastic heparan sulfate regulates osteoprotegerin function and bone mass.

Nozawa S, Inubushi T, Irie F, Takigami I, Matsumoto K, Shimizu K, Akiyama H, Yamaguchi Y.

JCI Insight. 2018 Feb 8;3(3). pii: 89624. doi: 10.1172/jci.insight.89624. [Epub ahead of print]

2.

Postnatal lethality and chondrodysplasia in mice lacking both chondroitin sulfate N-acetylgalactosaminyltransferase-1 and -2.

Shimbo M, Suzuki R, Fuseya S, Sato T, Kiyohara K, Hagiwara K, Okada R, Wakui H, Tsunakawa Y, Watanabe H, Kimata K, Narimatsu H, Kudo T, Takahashi S.

PLoS One. 2017 Dec 29;12(12):e0190333. doi: 10.1371/journal.pone.0190333. eCollection 2017.

3.

Heparin-fibronectin interactions in the development of extracellular matrix insolubility.

Raitman I, Huang ML, Williams SA, Friedman B, Godula K, Schwarzbauer JE.

Matrix Biol. 2018 Apr;67:107-122. doi: 10.1016/j.matbio.2017.11.012. Epub 2017 Dec 6.

PMID:
29223498
4.

Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.

Inubushi T, Lemire I, Irie F, Yamaguchi Y.

J Bone Miner Res. 2018 Apr;33(4):658-666. doi: 10.1002/jbmr.3341. Epub 2017 Nov 30.

PMID:
29120519
5.

Genome‑wide analysis and prediction of functional long noncoding RNAs in osteoblast differentiation under simulated microgravity.

Hu Z, Wang H, Wang Y, Zhou H, Shi F, Zhao J, Zhang S, Cao X.

Mol Med Rep. 2017 Dec;16(6):8180-8188. doi: 10.3892/mmr.2017.7671. Epub 2017 Sep 29.

6.

Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis.

You WK, Stallcup WB.

Cancers (Basel). 2017 Jul 28;9(8). pii: E97. doi: 10.3390/cancers9080097.

7.

Aberrant perichondrial BMP signaling mediates multiple osteochondromagenesis in mice.

Inubushi T, Nozawa S, Matsumoto K, Irie F, Yamaguchi Y.

JCI Insight. 2017 Aug 3;2(15). pii: 90049. doi: 10.1172/jci.insight.90049. [Epub ahead of print]

8.

The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications.

Ayerst BI, Merry CLR, Day AJ.

Pharmaceuticals (Basel). 2017 Jun 13;10(2). pii: E54. doi: 10.3390/ph10020054. Review.

9.

Hereditary Multiple Exostoses: New Insights into Pathogenesis, Clinical Complications, and Potential Treatments.

Pacifici M.

Curr Osteoporos Rep. 2017 Jun;15(3):142-152. doi: 10.1007/s11914-017-0355-2. Review.

PMID:
28466453
10.

Unsuspected osteochondroma-like outgrowths in the cranial base of Hereditary Multiple Exostoses patients and modeling and treatment with a BMP antagonist in mice.

Sinha S, Mundy C, Bechtold T, Sgariglia F, Ibrahim MM, Billings PC, Carroll K, Koyama E, Jones KB, Pacifici M.

PLoS Genet. 2017 Apr 26;13(4):e1006742. doi: 10.1371/journal.pgen.1006742. eCollection 2017 Apr.

11.

SMOC can act as both an antagonist and an expander of BMP signaling.

Thomas JT, Eric Dollins D, Andrykovich KR, Chu T, Stultz BG, Hursh DA, Moos M.

Elife. 2017 Mar 21;6. pii: e17935. doi: 10.7554/eLife.17935.

12.

EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay.

Volpi S, Yamazaki Y, Brauer PM, van Rooijen E, Hayashida A, Slavotinek A, Sun Kuehn H, Di Rocco M, Rivolta C, Bortolomai I, Du L, Felgentreff K, Ott de Bruin L, Hayashida K, Freedman G, Marcovecchio GE, Capuder K, Rath P, Luche N, Hagedorn EJ, Buoncompagni A, Royer-Bertrand B, Giliani S, Poliani PL, Imberti L, Dobbs K, Poulain FE, Martini A, Manis J, Linhardt RJ, Bosticardo M, Rosenzweig SD, Lee H, Puck JM, Zúñiga-Pflücker JC, Zon L, Park PW, Superti-Furga A, Notarangelo LD.

J Exp Med. 2017 Mar 6;214(3):623-637. doi: 10.1084/jem.20161525. Epub 2017 Feb 1.

13.

Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis.

Matsuo I, Kimura-Yoshida C.

Philos Trans R Soc Lond B Biol Sci. 2014 Dec 5;369(1657). pii: 20130545. doi: 10.1098/rstb.2013.0545. Review.

14.

Human genetic disorders and knockout mice deficient in glycosaminoglycan.

Mizumoto S, Yamada S, Sugahara K.

Biomed Res Int. 2014;2014:495764. doi: 10.1155/2014/495764. Epub 2014 Jul 13. Review.

15.

Immunohistochemical Localization of Bone Morphogenetic Proteins (BMPs) and their Receptors in Solitary and Multiple Human Osteochondromas.

Cuellar A, Inui A, James MA, Borys D, Reddi AH.

J Histochem Cytochem. 2014 Jul;62(7):488-98. doi: 10.1369/0022155414535781. Epub 2014 Apr 30.

16.

Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.

Sgariglia F, Candela ME, Huegel J, Jacenko O, Koyama E, Yamaguchi Y, Pacifici M, Enomoto-Iwamoto M.

Bone. 2013 Nov;57(1):220-31. doi: 10.1016/j.bone.2013.08.012. Epub 2013 Aug 17.

17.

Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses.

Huegel J, Sgariglia F, Enomoto-Iwamoto M, Koyama E, Dormans JP, Pacifici M.

Dev Dyn. 2013 Sep;242(9):1021-32. doi: 10.1002/dvdy.24010. Epub 2013 Jul 29. Review.

18.

Cell biology of osteochondromas: bone morphogenic protein signalling and heparan sulphates.

Cuellar A, Reddi AH.

Int Orthop. 2013 Aug;37(8):1591-6. doi: 10.1007/s00264-013-1906-5. Epub 2013 Jun 15. Review.

19.

Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.

Huegel J, Mundy C, Sgariglia F, Nygren P, Billings PC, Yamaguchi Y, Koyama E, Pacifici M.

Dev Biol. 2013 May 1;377(1):100-12. doi: 10.1016/j.ydbio.2013.02.008. Epub 2013 Mar 1.

20.

Heparan sulfate facilitates FGF and BMP signaling to drive mesoderm differentiation of mouse embryonic stem cells.

Kraushaar DC, Rai S, Condac E, Nairn A, Zhang S, Yamaguchi Y, Moremen K, Dalton S, Wang L.

J Biol Chem. 2012 Jun 29;287(27):22691-700. doi: 10.1074/jbc.M112.368241. Epub 2012 May 3.

Supplemental Content

Support Center